New Drug Product: Imbruvica

Treatment of patients with mantle cell lymphoma (MCL) or chronic lymphocytic leukemia (CLL) who have received at least one prior therapy.

Depression in Cancer Patients

Patients with cancer and depression frequently do not receive effective treatment.

Diabetes Risk for Lymphoma Survivors

Para-aortic radiation correlates with increased diabetes mellitus risk for Hodgkin's lymphoma survivors.

Colonic Diverticular Disease, Cancer

Colonic diverticular disease does not appear to be linked to an increased risk of subsequent colorectal cancer.

Botulinum Toxin as Cancer Treatment?

The therapeutic effects of systemic chemotherapy were enhanced by vagotomy or botulinum toxin type A treatment in a study.

Active Surveillance for Testicular Cancer

Active surveillance for clinical stage I (CSI) testis cancer leads to excellent outcomes.

NSAIDs, Breast Cancer Recurrence

Daily use of NSAIDs may reduce the recurrence rate of hormone-responsive breast cancer in overweight or obese women.

Prostate Cancer Treatments

Review this new chart on FDA-approved prostate cancer treatments for quick information when you need it.

News

9-Valent HPV Vaccine Promising for Cervical Cancer Prevention

9-Valent HPV Vaccine Promising for Cervical Cancer Prevention

A vaccine meant to protect against nine types of human papillomavirus (HPV) could prevent 90% of all cervical cancers.

Obesity Tied to Higher Cancer Risk for CRC Survivors

Obesity Tied to Higher Cancer Risk for CRC Survivors

Colorectal cancer (CRC) patients who are overweight or obese when diagnosed appear to face a slightly higher risk for developing a second weight-related cancer.

Increased Toxicity for Many Newly Approved Anticancer Drugs

Increased Toxicity for Many Newly Approved Anticancer Drugs

Newly approved anticancer drugs that do not have a specific molecular target on cancer cells are associated with increased toxicity and the accompanying costs of management.

Dim Light at Night Could Up Doxorubicin Resistance

Dim Light at Night Could Up Doxorubicin Resistance

A study hints that exposure to dim light at night may make human breast cancer tumors resistant to doxorubicin.

Low Professional Liability for No Esophageal Cancer Screening

Low Professional Liability for No Esophageal Cancer Screening

The risk of medical professional liability claims alleging failure to screen for esophageal cancer is not a reason to screen for esophageal cancer, according to a newly published research letter.

Charts

Make prescribing decisions with our comparative charts and treatment algorithms.

Calculators

Quickly and accurately perform clinical calculations.

Patient Information Fact Sheets

Download or print easy-to-read disease leaflets for your patients.

Featured courses from mycme

The Brigham Board Review in Hematology and OncologyExternal web site

The Brigham Board Review in Hematology and Oncology offers expert preparation for your ABIM subspecialty ...

CME 42.00 Credits

Comprehensive Review of Radiation OncologyExternal web site

Radiation oncologists and residents will appreciate the experience of the renowned faculty of the Comprehensive ...

CME 23.00 Credits

Understanding Current and Emerging Therapies for Head and Neck CancersExternal web site

This activity can help oncology nurses refresh their knowledge of the risks and treatments for ...

CE 0.50 Credits

Sign Up for Free e-newsletters